ArticleImmunology2001

Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity.

G P Geba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.